The spread of the coronavirus disease 2019 (COVID-19) pandemic caused a sudden and
significant disruption in healthcare services, especially for patients suffering from chronic …

Objective To determine how the COVID-19 pandemic impacts patients with chronic disease
medication adherence. Methods Four electronic databases, PubMed, MEDLINE, Web of …

Background Nonadherence to immune-modifying therapy is a complex behaviour which,
before the COVID-19 pandemic, was shown to be associated with mental health disorders in …

Psoriasis is a chronic inflammatory disease that profoundly affects a patient's life and is
comparable to chronic diseases, such as hypertension, heart failure, and depression. 1 The …

Background Since psoriasis is a chronic disease, it is not recommended to discontinue the
treatment agents used. However, in real life, the treatment of psoriasis patients may be …

Background Limited data are available characterizing the impact of the SARS-CoV-2
pandemic on psoriasis care for patients in Germany. Objective To analyze patient perception …

Background Illness perceptions in psoriasis have an impact on adherence and disability.
Changes in dermatological healthcare provision during the Covid‐19 pandemic and distress …

Abstract The coronavirus disease 2019 (COVID-19) pandemic raised many challenges for
dermatology. Safety is a principal concern for many patients, particularly those on …

Dear Editor, We read with great interest the article published by Oguz Topal et al. 1 titled
“Adherence to systemic therapy in patients with psoriasis during the COVID-19 pandemic: A …

Aim: Disease-related immune dysfunction and/or treatment with immunosuppressive drugs
may affect the course of coronavirus disease-2019 (COVID-19) infection in rheumatic …